ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

DCT Survey Shatters Myth That Young Investigator Have Difficulty Getting Grants – They’re Doing Better Than Those Over Age 40

August 3, 1984

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December 10, 2004

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

“Projects For Special Donors” – ACS Considering Way To Raise Vast New Sums For Cancer Program

March 31, 1978

NCI Advisory Group, Other Cancer Meetings

August 30, 1991